Dispute Within CDC Over Zika Testing

An agency scientist who accused the Centers for Disease Control and Prevention of suppressing disagreements over the accuracy of a diagnostic test obtains whistleblower protection.

Written byBen Andrew Henry
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, NIAID

Federal documents released to the public this week (September 27) reveal an ongoing dispute within the US Centers for Disease Control and Prevention (CDC) over how to screen for Zika virus infection, as first reported by The Washington Post. According to the Washington Post, the agency demoted a top researcher in May who had accused the CDC of withholding evidence from state and local laboratories, suggesting that current tests are less effective than alternative ones, then later reinstated his position after he invoked legal protection as a whistleblower.

News of the conflict came to light after the Office of Special Counsel (which handles whistleblower complaints) released documents containing an intra-CDC investigation on the matter.

The dispute began last spring, the documents show, when the public ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies